Sponsored Breakfast Symposium
A Discussion of Distressing Low Desire: A Novel Medicine for an Undertreated Condition
Friday, November 15, 2019
07:15 a.m. - 08:15 a.m.
Participants will learn about Hypoactive Sexual Desire Disorder (HSDD), a long-recognized yet undertreated medical condition; and be introduced to the first and only as-needed treatment that has been FDA approved for premenopausal women with acquired, generalized HSDD.
Brooke Faught, DNP, WHNP-BC, IF
Lisa Larkin, MD, FACP, NCMP, IF